Established in 2010, Pharmazz, Inc. is an emerging global pharmaceutical company. Focus of the company is to discover, acquire, develop and market novel pharmaceutical products for use in critical care and hospital settings.

Pharmazz conducts studies that lead to the discovery and development of products for the diagnosis and treatment of clinical conditions that require critical care and hospital settings.

The company conducts regulatory studies with the aim of getting market approval of novel drugs or expanding the market size of commercialized products.

Pharmazz constantly assesses global healthcare developments and strategically positions its products to maximize benefit and use for patients.

Pharmazz has established its subsidiary in India (Pharmazz India Private Limited) and in UK (Pharmazz UK Limited). Pharmazz's in-house Research and Development facility has been recognized and approved by Department of Scientific and Industrial Research (DSIR), Ministry of Science and Technology, Government of India. Pharmazz has also received funding from National Institute of Health, USA.